Pantothenate biosynthesis in Toxoplasma gondii tachyzoites is not a drug target

Agrawal, 2019, EL-MAVEN: a fast, robust, and user-friendly mass spectrometry data processing engine for metabolomics Akinnusi, 2011, Geminal dialkyl derivatives of N-substituted pantothenamides: synthesis and antibacterial activity, Bioorg. Med. Chem., 19, 2696, 10.1016/j.bmc.2011.02.053 Alday, 2017, Drugs in development for toxoplasmosis: advances, challenges, and current status, Drug Des. Dev. Ther., 11, 273, 10.2147/DDDT.S60973 Butman, 2020, Vitamin in the crosshairs: targeting pantothenate and coenzyme A biosynthesis for new antituberculosis agents, Front. Cell. Infect. Microbiol., 10, 10.3389/fcimb.2020.605662 Carey, 2000, Identification and molecular characterization of GRA8, a novel, proline-rich, dense granule protein of Toxoplasma gondii, Mol. Biochem. Parasitol., 105, 25, 10.1016/S0166-6851(99)00160-7 2021 Chambers, 2012, A cross-platform toolkit for mass spectrometry and proteomics, Nat. Biotechnol., 30, 918, 10.1038/nbt.2377 Chiarelli, 2018, A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK, Sci. Rep., 8, 3187, 10.1038/s41598-018-21614-4 Clasquin, 2012, LC-MS data processing with maven: a metabolomic analysis and visualization engine, Current Protocols in Bioinformatics, 37, 10.1002/0471250953.bi1411s37 Cronan, 1982, Genetic and biochemical analyses of pantothenate biosynthesis in Escherichia coli and Salmonella typhimurium, J. Bacteriol., 149, 916, 10.1128/jb.149.3.916-922.1982 Dubey, 1997, Oocyst-induced murine toxoplasmosis: life cycle, pathogenicity, and stage conversion in mice fed Toxoplasma gondii oocysts, J. Parasitol., 83, 870, 10.2307/3284282 Gubbels, 2003, High-throughput growth assay for Toxoplasma gondii using yellow fluorescent protein, Antimicrob. Agents Chemother., 47, 309, 10.1128/AAC.47.1.309-316.2003 Hung, 2009, Application of fragment growing and fragment linking to the discovery of inhibitors of Mycobacterium tuberculosis pantothenate synthetase, Angew. Chem. Int. Ed., 48, 8452, 10.1002/anie.200903821 Hung, 2016, Optimization of inhibitors of Mycobacterium tuberculosis pantothenate synthetase based on group efficiency analysis, ChemMedChem, 11, 38, 10.1002/cmdc.201500414 Jacot, 2020, Chapter 20 - genetic manipulation of Toxoplasma gondii Jerome, 1998, Toxoplasma gondii bradyzoites form spontaneously during sporozoite-initiated development, Infect. Immun., 66, 4838, 10.1128/IAI.66.10.4838-4844.1998 Katris, 2014, The apical complex provides a regulated gateway for secretion of invasion factors in Toxoplasma, PLoS Pathog., 10, 10.1371/journal.ppat.1004074 King, 1974, Ketopantoyl Lactone and Ketopantoic Acid Reductases: characterization of the reactions and purification of two forms of ketopantoyl lactone reductase, J. Biol. Chem., 249, 4689, 10.1016/S0021-9258(19)42375-2 Kumar, 2007, How pantothenol intervenes in Coenzyme-A biosynthesis of Mycobacterium tuberculosis, Biochem. Biophys. Res. Commun., 361, 903, 10.1016/j.bbrc.2007.07.080 Leonardi, 2007, Biosynthesis of pantothenic acid and coenzyme A, EcoSal Plus, 2, 2, 10.1128/ecosalplus.3.6.3.4 Lunghi, 2022, Pantothenate biosynthesis is critical for chronic infection by the neurotropic parasite Toxoplasma gondii, Nature Commun., 13, 345, 10.1038/s41467-022-27996-4 Mageed, 2014, Pantothenic acid biosynthesis in the parasite Toxoplasma gondii: a target for chemotherapy, Antimicrob. Agents Chemother., 58, 6345, 10.1128/AAC.02640-14 Moncada, 2012, Toxoplasmosis in the fetus and newborn: an update on prevalence, diagnosis and treatment, Expert Rev. Anti-infect. Ther., 10, 815, 10.1586/eri.12.58 Naquet, 2020, Regulation of coenzyme A levels by degradation: the ‘ins and outs, Prog. Lipid Res., 78, 10.1016/j.plipres.2020.101028 Olzhausen, 2009, Genetic analysis of coenzyme A biosynthesis in the yeast Saccharomyces cerevisiae: identification of a conditional mutation in the pantothenate kinase gene CAB1, Curr. Genet., 55, 163, 10.1007/s00294-009-0234-1 Parker, 2019, The tyrosine transporter of Toxoplasma gondii is a member of the newly defined apicomplexan amino acid transporter (ApiAT) family, PLoS Pathog., 15, 10.1371/journal.ppat.1007577 Radke, 2018, Evaluation of current and emerging antimalarial medicines for inhibition of Toxoplasma gondii growth in vitro, ACS Infect. Dis., 4, 1264, 10.1021/acsinfecdis.8b00113 Rajendran, 2017, Cationic amino acid transporters play key roles in the survival and transmission of apicomplexan parasites, Nat. Commun., 8, 10.1038/ncomms14455 Raman, 2004, Pantothenate synthesis in plants, Plant Sci., 167, 961, 10.1016/j.plantsci.2004.06.019 Saliba, 1998, Transport and metabolism of the essential vitamin pantothenic acid in human erythrocytes infected with the malaria parasite Plasmodium falciparum, J. Biol. Chem., 273, 10190, 10.1074/jbc.273.17.10190 Sambandamurthy, 2002, A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis, Nat. Med., 8, 1171, 10.1038/nm765 Sheiner, 2011, A systematic screen to discover and analyze apicoplast proteins identifies a conserved and essential protein import factor, PLoS Pathog., 7, 10.1371/journal.ppat.1002392 Shen, 2014, Efficient gene disruption in diverse strains of Toxoplasma gondii using CRISPR/CAS9, mBio, 5, 10.1128/mBio.01114-14 Spry, 2008, Coenzyme A biosynthesis: an antimicrobial drug target, FEMS Microbiol. Rev., 32, 56, 10.1111/j.1574-6976.2007.00093.x Strauss, 2010, Coenzyme A biosynthesis and enzymology Tanuma, 2016, Incidence of AIDS-defining opportunistic infections and mortality during antiretroviral therapy in a cohort of adult HIV-infected individuals in hanoi, 2007-2014, PLoS One, 11, 10.1371/journal.pone.0150781 Tenter, 2000, Toxoplasma gondii: from animals to humans, Int. J. Parasitol., 30, 1217, 10.1016/S0020-7519(00)00124-7 Tjhin, 2021, A novel heteromeric pantothenate kinase complex in apicomplexan parasites, PLoS Pathog., 17, 10.1371/journal.ppat.1009797 van Dooren, 2008, Toxoplasma gondii Tic20 is essential for apicoplast protein import, Proc. Natl. Acad. Sci. USA, 105, 13574, 10.1073/pnas.0803862105 Wang, 2003, Crystal structures of a pantothenate synthetase from M. tuberculosis and its complexes with substrates and a reaction intermediate, Protein Sci., 12, 1097, 10.1110/ps.0241803 Zamboni, 2009, 13C-based metabolic flux analysis, Nat. Protoc., 4, 878, 10.1038/nprot.2009.58 Zheng, 2001, Steady-state and pre-steady-state kinetic analysis of Mycobacterium tuberculosis pantothenate synthetase, Biochemistry, 40, 12904, 10.1021/bi011522+